SAPROPTERIN
sapropterin dihydrochloride 500 mg powder for oral liquid, 30 sachets
SAPROPTERIN (11970B)
11970B
Manner of administration:Oral
Restriction
Indication: Hyperphenylalaninaemia (HPA) due to tetrahydrobiopterin (BH4) deficiency
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $4,043.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Kuvan | |||||
